Global Cardiology Conference is pleased to announce
Call For Abstracts Programme

Participate in the Global Cardiology Conference 2024, by sharing your research and papers on cardiovascular fields.

Abstract Submission Starts

10th February 2024

Last Date for Abstract Submission

10th March 2024


GCCCardio allows you to showcase your work to a wide audience of academia, researchers, cardiologists, healthcare professionals, and policymakers across the globe. Presenting your abstract will highlight best practices, share innovative ideas and knowledge in the field.

Do not miss the opportunity to take part in the inaugural Middle East edition of the Global Cardiology Conference.

Please read the following submission guidelines.

SUBMIT YOUR SCIENCE

For any additional questions, please drop an email to abstracts@globalcardiologyconference.com.

Abstract Categories and Topics:

Basic Science

Category
  • Abstracts Topic related to
Arteriosclerosis, Thrombosis and Vascular Biology
  •  Atherosclerosis
  •  Haemostasis
  •  Thrombosis and Fibrinolysis
  •  Microcirculation and Cerebral/Coronary/Peripheral
  • Circulation
  • Inflammation and Adhesion Molecules
Cardiac Development, Structure and Function
  •  Cardiac Hypertrophy
  • Heart Failure
  •  Ventricular Remodelling
Drug Discovery
  •  Newer Drugs For Treating Cardiovascular Disease
Genetics and Genomics
  •  Genetic Epidemiology, Genomics
  • Pharmacogenomics of Cardiovascular Disease
  •  Inherited Cardiac Disease
Metabolism and Physiology
  • Cardiorenal Physiology/Pathophysiology
  • Ischemic Myocardium
  • Electrophysiology and Experimental Models of Arrhythmias

Clinical Science

Acute Coronary Syndromes &Interventional Cardiology
  • Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology
  • Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacologic Therapy
  • Chronic Ischemic Heart Disease
  • Clinical Biomarkers
Cardio Oncology
  • Cardio Oncology
Congenital Heart Disease
  •  Adult Congenital Heart Disease
Electrophysiology and Arrhythmias
  • Arrhythmia: Clinical Electrophysiology Diagnosis
  • Arrhythmia: Clinical Electrophysiology Risk Stratification
  • Treatment of Arrhythmias: Pharmacologic
  • Treatment of Arrhythmias: Ablation and Surgery
  • Treatment of Arrhythmias: Device Therapy
Heart Failure, Cardiomyopathies & Inherited Heart Diseases
  • Heart Failure and Cardiomyopathies: Diagnosis & Evaluation
  • Heart Failure and Cardiomyopathies: Pathophysiology
  • Heart Failure and Cardiomyopathies: Pharmacologic Therapy
  • Heart Failure and Cardiomyopathies: Pacing and Other Therapeutic Devices
  • Heart Failure and Cardiomyopathies: Disease Management
  • Heart Failure and Cardiomyopathies: Quality of Care, and Clinical Outcomes
  • Medical Aspects End Stage Heart Failure: Transplantation and Device Therapies
  • Inherited Heart Disease
  • Myocardial Function/Hemodynamics and Biomarkers/Pericardial Disease
  • Care Transitions to Outpatient Palliative and End of Life Care
Hypertension
  • Experimental
  • Clinical
Vascular Disease and Thrombosis
  • Vascular Medicine Non-coronary
Imaging
  • Echocardiography: Evaluation of Systolic and Diastolic Function
  •  Echocardiography: Emerging new techniques including 3D- Echo, Myocardial
  • Strain Imaging, Contrast & Multi modalities or Fusion imaging and Structural Heart Disease Intervention
  • Echocardiography in Clinical Syndromes: CAD, Stress Echo, Endocarditis, Stroke, Arrhythmias, Systemic Disease
  • Computed Tomography (CT): Heart (Coronary and Non-coronary
  • Magnetic Resonance Imaging (MRI): Heart
  • Non-Coronary Vascular Imaging(CT/MRI/Other)
Arrhythmias
  • Arrhythmia: Clinical Electrophysiology Diagnosis
  • Arrhythmia: Clinical Electrophysiology Risk Stratification
  • Treatment of Arrhythmias: Pharmacologic
  • Treatment of Arrhythmias: Ablation and Surgery
  • Treatment of Arrhythmias: Device Therapy
Interventional Treatment
  •  Pharmacology for ACS and PCI
  • Catheter-Based Coronary Interventions
  • Endovascular Therapy
  • Percutaneous Non-Coronary Cardiac Intervention (including Percutaneous Valves)
  • Catheter-Based Coronary Imaging and Hemodynamic

  Broad Focus Topics

COVID-19
  •  Basic Science and Pathophysiology
  • Clinical Perspectives
  • Epidemiology

  Population Science

Cardiometabolic Health and Diabetes
  • Obesity and Weight Management in CVD Risk and Prevention Lifestyle
  •  Diabetes Mellitus and CVD: Prevention and Management Lifestyle
  • Cardiovascular Kidney and Metabolic Health
Women’s Heart Health and Underrepresented Populations
  • Women’s Health and Sex Differences
  • Aging and Care of the Older Adult
  • Health Disparities
  • Maternal Health
  • LGBTQ+ Health
Nursing Research and Clinical
  • Primary Care, Prevention, Education, and Disease Management
  •  Psychosocial and Behavioral Aspects
  •  Physiologic Aspects of Acute and Chronic Care
Epidemiology
  • Preventive Interventions: Population and Clinical Trials
  • Epidemiology and Population Studies
  •  Clinical and Hospital-Based Observational Studies
  • Social Determinants of Health
  • Health Equity and Structural Racism
  • Implementation Science
Lifestyle
  • Nutrition in CVD Risk and Prevention
  • Exercise, Physical Activity and Rehabilitation
  •  Workplace, Environmental and Culture of Health Substance Use and CVD: Nicotine, Marijuana and Other Drugs
  • Sleep Health
General Cardiology & Others

Global Cardiology Conference
Submission Guidelines for General Abstract

  • All abstracts must be submitted (and if accepted, will be presented) in English having accurate grammar and spelling are suitable for publication.
  • Statistical results (including descriptive and inferential statistics) are to be included.
  • The author must affirm the work submitted is original and that all statements declared as facts are based on thorough examination and investigation for accuracy.
  • Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals will be disqualified.
  • Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to present, if not justified, will jeopardize future acceptance of abstracts for GCC meetings/conferences.

Abstract Title

  • An abstract must have a short, specific title (containing no abbreviations or inflammatory language) that indicates the nature of the investigation.
  • Avoid an abstract title that reveals the results of the study. Explicit titles denoting the findings should be used (not “Investigations of…,” “Studies of…,” etc.)

Abstract Text

It is recommended abstracts have the following identifiable sections:

  • Introduction/Background
  • Research Questions/Hypothesis
  • Goals/Aims
  • Methods/Approach
  • Results/Data (descriptive and inferential statistics)
  • Conclusion(s)

Do not include references, credits or grant support.

Abstract Character Guidelines:

  • Abstracts are limited to 1,950 characters (about 300-350 words).
  • Spaces do not count as characters.
  • Counts towards Character Limit:
    • Text in the abstract body
    • Graphics – The addition of an image whether a figure or a table deducts 250 characters.
  • Does not count towards character limit:
    • Title of abstract
    • Names of authors
    • Spaces in the abstract body
    • Caption of graphic

Graphics Guidelines

  • All graphics (figures) and text-based graphics (tables) should be provided as 72-300 dpi, pre-sized. BMP, GIF. JPG or .PNG images only, with a maximum width of 440 pixels (no limit on length). Black-and-white digital images should be in grayscale mode. Colour images should be saved in RGB colour mode.
  • All graphics will require a brief description of the image.

SAMPLE ABSTRACT

 

 Presentation Title 

Author and Co-author Names

  • Department or Division Name, Organisation/Affiliation, City, State, Country, Email
  • Department or Division Name, Organisation/Affiliation, City, State, Country, Email

 Presenter Name

Abstract Title

  • A short, specific title (containing no abbreviations or inflammatory language) that indicates the nature of the investigation.
  • Avoid an abstract title that reveals the results of the study. Explicit titles denoting the findings should be used (not “Investigations of…,” “Studies of…,” etc.)

Abstract Text*

The abstract should have the following distinct categories (about 300 – 350 words)

  1. Introduction/Background
  2. Research Questions/Hypothesis
  3. Goals/Aims
  4. Methods/Approach
  5. Results/Data (descriptive and inferential statistics)
  6. Conclusion(s)

Figure/Table

Only one figure/table can be included. Please ensure the image used is high quality.

Biography of presenting author (should not exceed 100 words)

(Example: Dr Liza studied Chemistry at Sofia University, Bulgaria, graduating with an MS in 1999. She then joined the research group of Prof. James at the Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences (IGIC-BAS). She received her PhD degree in 2004 at the same institution. After one year of postdoctoral fellowship supervised by Dr Williams at the Catalysis and Spectrochemistry Laboratory, in France, she obtained the position of an Associate Professor at the IGIC. She has published more than 70 research articles in SCI(E) journals.)

Details of presenting author to be mentioned in the certificate:

  • Name:
  • Affiliation:
  • Country:

Other Details:

  • Presentation Category:
  • Session Name:
  • Email:
  • Alternative Email:
  • Contact Number:
  • WhatsApp Number:
  • Twitter/Facebook/LinkedIn:
  • The suggestion of speakers to be invited: Names and email addresses of your colleagues or friends interested to attend.